Recon: WHO cites concerns about Sputnik V plant; GSK’s drug arm to get $11B windfall from consumer spin-off
ReconMichael Mezher
BiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticalsReconMichael MezherBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticals